Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...

APG-808 is under clinical development by Apogee Therapeutics and currently in Phase I for Unspecified Immunological Disorders.

Scientists at Newcastle University have developed a new lung scanning method that reveals the real-time effects on lung ...

New imaging techniques reveal real-time lung function improvements, offering a breakthrough in diagnosing and treating ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a study published online Nov. 27 in The ...

First New Treatment for Asthma Attacks in 50 Years Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of ...

Those key challenges impacting the care of respiratory diseases include delays in diagnosis due to the intermittent nature of ...

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Scientists at Newcastle University in the UK have developed a groundbreaking scanning technique that shows how lungs work ...

Samuel Louie; Amir A Zeki; Michael Schivo; Andrew L Chan; Ken Y Yoneda; Mark Avdalovic; Brian M Morrissey; Timothy E Albertson The Spanish COPD guidelines propose four COPD phenotypes that ...

Demonstrating that the scans work in patients with asthma or COPD, the team comprising experts from across Universities and ...